BIO’s board chair, Dr. Ted Love, said Crowley stood out for his experience as a biotech CEO as well as the breadth of his connections with lawmakers, executives and patients. “John is a guy ...

John F. Crowley is CEO of Amicus Therapeutics. Crowley’s involvement with biotechnology stems from the 1998 diagnosis of two of his children with Pompe disease—a severe and often fatal ...

When Megan was diagnosed with an extremely rare disease as a baby, her father, John Crowley, founded a small biotechnology start-up to try to cure Megan and her brother — an effort that ...

Orlando and Orange County agreed to offer tax incentives to coax a New Jersey biotech company to build ... Inc. Chairman and CEO John Crowley was the subject of a nonfiction book, “The Cure ...

“Our adversaries abroad have stated that they intend to become the biotechnology centre of excellence in the world,” said BIO’s new chief executive, John Crowley, in a statement. “America ...

John Crowley, whose romantic drama We Live in Time is currently breaking hearts on the fall film festival circuit, has signed ...

BIO CEO, John Crowley, stated: “Our adversaries abroad have stated that they intend to become the biotechnology centre of excellence in the world. America and our allies cannot let this happen.

“Bob was gone for most of my early childhood,” says John, who was only five when ... “No!” say the Crowley brothers in unison. “We talk about records!” ...

But the script for the romantic dramedy starring Andrew Garfield and Florence Pugh has a different ending than what viewers ended up seeing on screen, the film’s director John Crowley tells ...

City Therapeutics, based in Cambridge, is developing new medicines that use RNA interference, or RNAi, to silence genes and ...

The former CEO of Alnylam spoke with STAT about raising money to focus on one big idea, and the prospect for a $100 billion Alnhylam.

City Therapeutics has launched with $135 million and Alnylam’s former CEO leading the charge as it develops a pipeline of ...